HCPLive

New Agent Significantly Improves Progression-Free Survival in Patients With Advanced ER+ Breast Cancer

Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.

Click here to view this article.

Most Popular

Recommended Reading

Classifying breast cancers according to tumor subtypes could help improve treatment of the disease, according to a new statement from four major medical groups focused on the disease. The report was published online March 30 in the Journal of the National Cancer Institute.

Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer, according to a new study published online March 17 in Breast Cancer Research and Treatment.

High intake of fish and long-chain ω-3 polyunsaturated fatty acids (PUFAs) is associated with reduced all-cause mortality after breast cancer, according to a study published online March 24 in Cancer.

For women with early-stage breast cancer, cognitive-behavioral stress management (CBSM) delivered after surgery is associated with long-term psychological benefits, according to a study published online March 23 in Cancer.

$vAR$